Hims & Hers reports strong Q2 revenue growth but wider loss amid legal challenges

Hims & Hers Health reported Q2 revenue of $753.21 million, up 38% year-over-year, beating estimates. However, the company posted a wider-than-expected GAAP loss of $0.37 per share due to declining gross margins and rising operating expenses. Legal troubles surfaced as the FTC and others filed a lawsuit alleging data sharing and deceptive practices, prompting a securities investigation. Despite these issues, the company raised its 2026 revenue guidance but lowered its adjusted EBITDA forecast, reflecting ongoing profitability pressures from expansion efforts.